Xue J, Kuo N-W, Schill M, LiWang PJ. A comparison of 5P12-vMIP-II and vMIP-II as HIV-1 entry inhibitors. Biochemistry and Physiology. 2013. doi:0.1371/journal.pone.0064132
Publications
2013
Xue J, Kuo N-W, Schill M, LiWang PJ. A comparison of 5P12-vMIP-II and vMIP-II as HIV-1 entry inhibitors. Biochemistry and Physiology. 2013. doi:10.4172/2168-9652.S2-005
Hoorelbeke B, Xue J, LiWang PJ, Balzarini J. Role of the carbohydrate-binding sites of griffithsin in the prevention of DC-SIGN-mediated capture and transmission of HIV-1. PLoS ONE. 2013;(8(5): e64132.). doi:10.1371/journal.pone.0064132
Hoorelbeke B, van Montfort T, Xue J, LiWang PJ, Tanaka H, Igarashi Y, Vandamme EJ, Sanders R, Balzarini an. HIV-1 envelope trimer has similar binding characteristics for carbohydrate-binding agents as monomeric gp120. FEBS Letters. 2013;587:860–866.
Xue J, Hoorelbeke B, Kagiampakis I, Demeler B, Balzarini J, LiWang PJ. The griffithsin dimer is required for high potency inhibition of HIV-1: Evidence for manipulation of the structure of gp120 as part of the griffithsin dimer mechanism. Antimicrobial Agents and Chemotherapy. 2013;57:8:3976–3989.
2012
Xue J, Gao Y, Hoorelbeke B, Kagiampakis I, Zhao B, Demeler B, Balzarini J, LiWang PJ. The role of individual carbohydrate-binding sites in the function of the potent anti-HIV lectin Griffithsin. Molecular Pharmaceutics. 2012;4:2613–2625.
2011
Kagiampakis I, Gharibi A, Mankowski MK, Snyder BA, Ptak RG, Alatas K, LiWang PJ. A Potent Strategy to Inhibit HIV by binding both gp120 and gp41. Antimicrobial Agents and Chemotherapy. 2011;55:254–265.
Zhao B, Mankowski MK, Snyder BA, Ptak RG, LiWang PJ. Highly potent chimeric inhibitors targeting two steps of HIV cell entry. Biological Chemistry. 2011;286:28370–28381.
2010
Jin H, Kagiampakis I, Li P, LiWang PJ. Structural and Functional Studies of the Potent Anti-HIV Chemokine Variant P2-RANTES. Proteins:Structure, Function and Bioinformatics. 2010;78:295–308.
Zhao B, LiWang PJ. Characterization of the interactions of vMIP-II, and a dimeric variant of vMIP- II, with glycosaminoglycans. Biochemistry. 2010;49:7012–7022.